Offered under an Emergency Use Authorization (EUA), our test validation shows >99% sensitivity and 100% specificity within our test environment.

The assay is using a standard nasopharyngeal specimen from which Acutis extracts viral RNA and then tests for the presence of key genes that can be used to identify its presence.

The Acutis SARS-CoV-2 test is a multiplex assay that targets three key genes — ORF1ab, N,  and E — that scientists believe are key to accurately identifying the presence of the virus in patient samples. 

COVID-19 testing plans provide accurate results quickly, detecting the virus even when someone is asymptomatic. Early detection allows for earlier intervention, enabling employers to act fast to prevent the spread of COVID-19 among their workforce.   

Partnering with us will get you and your employees quicker results and keep your team moving 24 hours a day, 7 days per week. Learn more about working with Acutis Diagnostics as your COVID-19 testing partner.

Our Acutis Reveal™ COVID-19 Antibody test is a blood test that looks for antibodies to the coronavirus that generally arises after infection.

While this is not used to diagnose current disease, the antibody test offers insight into whether or not your patient has come in contact with the virus.     Learn more about our Acutis Reveal™ COVID-19 Antibody test that detects the IgG and IgM antibodies.